CPF alters gonadotropin-releasing hormone biosynthesis in GT1-7 hypothalamic cell lines [57]; both anti-androgenic [58] and estrogenic effects, inducing growth in breast cancer cells [59,60], have been observed. Here, NR5A2 is linked to breast carcinoma.